Aymeric Douillard, Marie-Christine Picot, Cécile Delcourt, Annie Lacroux, Xavier Zanlonghi, Bernard Puech, Sabine Defoort-Dhelemmes, Isabelle Drumare, Elsa Jozefowicz, Béatrice Bocquet, Corinne Baudoin, Nour Al-Dain Marzouka, Sarah Perez-Roustit, Sophie Arsène, Valérie Gissot, François Devin, Carl Arndt, Benjamin Wolff, Martine Mauget-Faÿsse, Maddalena Quaranta, Thibault Mura, Dominique Deplanque, Hassiba Oubraham, Salomon Yves Cohen, Pierre Gastaud, Olivia Zambrowsky, Catherine Creuzot-Garcher, Saddek Mohand Saïd, Rocio Blanco Garavito, Eric Souied, José-Alain Sahel, Isabelle Audo, Christian Hamel, Isabelle Meunier
PURPOSE: To assess the association of clinical and biological factors with extensive macular atrophy with pseudodrusen (EMAP) characterized by bilateral macular atrophy occurring in patients aged 50 to 60 years and a rapid progression to legal blindness within 5 to 10 years. DESIGN: A national matched case-control study. PARTICIPANTS: Participants were recruited in 10 French Departments of Ophthalmology and their associated clinical investigation centers...
September 2016: Ophthalmology